Healthcare provider profile · identity verified

Joseph Barbato, DO

Family Practice · NIAGARA FALLS, NY · NPI 1154778694

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	704	218
Levothyroxine Sodium	Levothyroxine Sodium	491	147
Amlodipine Besylate	Amlodipine Besylate	361	116
Rosuvastatin Calcium	Rosuvastatin Calcium	358	106
Losartan Potassium	Losartan Potassium	293	79
Omeprazole	Omeprazole	276	78
Metoprolol Succinate	Metoprolol Succinate	230	66
Lisinopril	Lisinopril	229	74
Hydrochlorothiazide	Hydrochlorothiazide	186	66
Albuterol Sulfate Hfa	Albuterol Sulfate	179	56
Ezetimibe	Ezetimibe	148	41
Gabapentin	Gabapentin	148	40
Enalapril Maleate	Enalapril Maleate	147	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	147	24
Alprazolam	Alprazolam	140	33
Metformin Hcl	Metformin Hcl	130	46
Pantoprazole Sodium	Pantoprazole Sodium	121	39
Sertraline Hcl	Sertraline Hcl	115	40
Baclofen	Baclofen	103	22
Duloxetine Hcl	Duloxetine Hcl	99	25
Alendronate Sodium	Alendronate Sodium	98	30
Irbesartan	Irbesartan	95	26
Pravastatin Sodium	Pravastatin Sodium	92	34
Tamsulosin Hcl	Tamsulosin Hcl	91	30
Fluoxetine Hcl	Fluoxetine Hcl	90	24
Jardiance	Empagliflozin	89	27
Metformin Hcl Er	Metformin Hcl	89	30
Ozempic	Semaglutide	89	22
Simvastatin	Simvastatin	89	30
Famotidine	Famotidine	86	23
Fluticasone Propionate	Fluticasone Propionate	86	38
Clopidogrel	Clopidogrel Bisulfate	83	17
Furosemide	Furosemide	79	26
Mirtazapine	Mirtazapine	79	19
Venlafaxine Hcl Er	Venlafaxine Hcl	79	20
Metoprolol Tartrate	Metoprolol Tartrate	77	23
Escitalopram Oxalate	Escitalopram Oxalate	76	21
Chlorthalidone	Chlorthalidone	73	20
Synthroid	Levothyroxine Sodium	73	21
Trazodone Hcl	Trazodone Hcl	71	20
Potassium Chloride	Potassium Chloride	66	21
Montelukast Sodium	Montelukast Sodium	65	15
Atenolol	Atenolol	63	24
Ibuprofen	Ibuprofen	63	17
Trulicity	Dulaglutide	62	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	59	suppressed
Carvedilol	Carvedilol	57	20
Allopurinol	Allopurinol	56	17
Buspirone Hcl	Buspirone Hcl	56	12
Eliquis	Apixaban	53	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	14
Pregabalin	Pregabalin	53	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	52	46
Torsemide	Torsemide	50	suppressed
Hydralazine Hcl	Hydralazine Hcl	48	16
Ketoconazole	Ketoconazole	48	25
Celecoxib	Celecoxib	46	suppressed
Spironolactone	Spironolactone	44	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	13
Meclizine Hcl	Meclizine Hcl	43	15
Ondansetron Odt	Ondansetron	43	21
Glimepiride	Glimepiride	42	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	42	suppressed
Ramipril	Ramipril	41	16
Bupropion Xl	Bupropion Hcl	40	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	40	suppressed
Prednisone	Prednisone	40	31
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	39	11
Clonazepam	Clonazepam	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	suppressed
Telmisartan-Amlodipine	Telmisartan/Amlodipine	39	16
Glipizide	Glipizide	38	13
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	13
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Telmisartan	Telmisartan	36	15
Valsartan	Valsartan	36	suppressed
Valacyclovir	Valacyclovir Hcl	35	14
Bisoprolol Fumarate	Bisoprolol Fumarate	34	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	31
Xarelto	Rivaroxaban	34	suppressed
Finasteride	Finasteride	33	suppressed
Naproxen	Naproxen	31	suppressed
Diazepam	Diazepam	28	15
Doxycycline Hyclate	Doxycycline Hyclate	28	26
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	27	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Premarin	Estrogens, Conjugated	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Folic Acid	Folic Acid	24	suppressed
Azithromycin	Azithromycin	23	20
Dilt-Xr	Diltiazem Hcl	23	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	16
Bumetanide	Bumetanide	20	suppressed
Primidone	Primidone	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Topiramate	Topiramate	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Naltrexone Hcl	Naltrexone Hcl	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Oxcarbazepine	Oxcarbazepine	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Nystatin	Nystatin	13	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	12	suppressed
Haloperidol	Haloperidol	11	suppressed
Prasugrel Hcl	Prasugrel Hcl	11	suppressed
Single Use Swab	Alcohol Antiseptic Pads	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error